Wearables enter medicine
- Clinicians are increasingly looking to wearable data for patient monitoring and oncology research. (healthleadersmedia.com) - HealthLeaders reports nearly 45% of Americans now own wearables, supplying that growing data stream. (healthleadersmedia.com) - MedCity cautions as wearable data explodes, trust will determine which metrics clinicians actually use in care. (medcitynews.com)
Doctors are starting to use data from smartwatches, rings and patches as a new stream of patient monitoring between office visits. (the-scientist.com) At the American Association for Cancer Research annual meeting in April 2026, researchers described wearables as tools for tracking behavior and physiology in daily life, not just during a clinic appointment. Carissa Low of the University of Pittsburgh Medical Center said the devices can capture what patients are doing and how their bodies respond between visits. (the-scientist.com) The data stream is getting bigger fast because the devices are already common. A recent survey cited by The Scientist found nearly 45% of Americans now own a wearable device. (the-scientist.com) A wearable is a sensor you keep on your body, like a watch that counts steps, a ring that tracks sleep, or a patch that records heart rhythm. In medicine, the appeal is continuous measurement: instead of one blood pressure or symptom report in a visit, clinicians can see patterns over days or weeks. (jamanetwork.com) Cancer care has become one of the clearest test cases. A 2024 systematic review in *The Oncologist* found studies using wearables for treatment monitoring, prognosis and rehabilitation planning in oncology patients. (academic.oup.com) Recent reporting from Cancer Today described research in which Fitbit and Apple Watch-style devices picked up changes in gait and physical function after cancer treatment, helping identify some patients at risk of hospital readmission after surgery. (cancertodaymag.org) Regulators are also drawing a line between wellness gadgets and data that can be used in research. In May 2024, the Food and Drug Administration qualified Apple’s atrial fibrillation history feature as the first digital health technology accepted under its Medical Device Development Tools program for a defined use in clinical studies. (fda.gov) Payment policy is moving in the same direction. The Centers for Medicare & Medicaid Services says Medicare covers remote patient monitoring, and its remote monitoring guidance page was updated on March 4, 2026 as providers expand billing for device-based care outside the exam room. (cms.gov) The bottleneck is not collecting numbers; it is deciding which numbers deserve clinical trust. In an April 2026 essay, MedCity News said clinicians need data reliable enough to guide care, support reimbursement and reassure patients, or the flood of wearable readings becomes review burden instead of usable medicine. (medcitynews.com) That leaves wearables in a middle ground in 2026: common enough to generate real-world health data at scale, but still under pressure to prove which signals belong in routine care. (the-scientist.com)
